E-Cadherin antibody [N3C2], Internal
GTX124178
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetCDH1
Overview
- SupplierGeneTex
- Product NameE-Cadherin antibody [N3C2], Internal
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:10000. ICC/IF: 1:100-1:1000. IP: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1.09 mg/ml
- ConjugateUnconjugated
- Gene ID999
- Target nameCDH1
- Target descriptioncadherin 1
- Target synonymsArc-1, BCDS1, CD324, CDHE, ECAD, LCAM, UVO, cadherin-1, CAM 120/80, E-cadherin 1, cadherin 1, E-cadherin (epithelial), cadherin 1, type 1, E-cadherin (epithelial), calcium-dependent adhesion protein, epithelial, cell-CAM 120/80, epididymis secretory sperm binding protein, epithelial cadherin, uvomorulin
- HostRabbit
- IsotypeIgG
- Protein IDP12830
- Protein NameCadherin-1
- Scientific DescriptionThis gene is a classical cadherin from the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function is thought to contribute to progression in cancer by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. Identified transcript variants arise from mutation at consensus splice sites. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Luo SD, Tsai HT, Hwang CF, et al. Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis. J Exp Clin Cancer Res. 2022,41(1):215. doi: 10.1186/s13046-022-02415-0Read this paper
- Chen YH, Chen CH, Chien CY, et al. Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study. BMC Cancer. 2021,21(1):979. doi: 10.1186/s12885-021-08726-3Read this paper
- Chen YH, Lu HI, Lo CM, et al. CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma. Cancers (Basel). 2021,13(16). doi: 10.3390/cancers13163982Read this paper
- Yu LY, Tseng TJ, Lin HC, et al. Synthetic dysmobility screen unveils an integrated STK40-YAP-MAPK system driving cell migration. Sci Adv. 2021,7(31). doi: 10.1126/sciadv.abg2106Read this paper
- Ling HH, Kuo CC, Lin BX, et al. Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer. Exp Cell Res. 2017,350(1):218-225. doi: 10.1016/j.yexcr.2016.11.024Read this paper
- Lee WT, Lee TH, Cheng CH, et al. Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting ERK-AP-1- and AKT-NF-κB-dependent MMP-9 and epithelial-mesenchymal transition expressions. Food Chem Toxicol. 2015,78:33-41. doi: 10.1016/j.fct.2015.01.012Read this paper





